Revvity, Inc.
RVTYRevvity, Inc. (RVTY) is a global provider of laboratory testing, diagnostic products, and healthcare solutions. The company focuses on advancing scientific research and medical diagnostics through innovative technologies and comprehensive testing services, supporting healthcare providers and research institutions worldwide.
Dividend History
Investors can expect a dividend payout of $0.07 per share, scheduled to be distributed in 60 days on February 6, 2026
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| February 6, 2026 | $0.07 | 2026-01-16 | 2026-01-16 |
| November 7, 2025 | $0.07 | 2025-10-17 | 2025-10-17 |
| August 8, 2025 | $0.07 | 2025-07-18 | 2025-07-18 |
| May 9, 2025 | $0.07 | 2025-04-17 | 2025-04-18 |
| February 7, 2025 | $0.07 | 2025-01-17 | 2025-01-17 |
Dividends Summary
- Revvity, Inc. has issued 89 dividend payments over the past 22 years
- The most recent dividend was paid 31 days ago, on November 7, 2025
- The highest dividend payed out to investors during this period was $0.07 per share
- The average dividend paid during this period was $0.07 per share.
Company News
Wall Street extended its record-setting streak with major indices hitting all-time highs after a breakthrough in US-China trade negotiations. Trade tensions eased with potential tariff threats averted and promising discussions between diplomatic representatives.
Revvity reported Q2 2025 financial results with $720 million revenue, exceeding estimates, but experiencing margin compression and slight earnings decline due to tariff pressures and challenging market conditions.
The global CRISPR gene editing market is projected to grow from USD 4.15 billion in 2024 to USD 16.47 billion by 2034, driven by technological advancements, increasing investments, and growing applications in biotechnology and healthcare.
Pediatrix Medical Group (MD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
